Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 310

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Adriamycin cardiomyopathy: pathophysiology and prevention

Singal, Pawan K., Iliskovic, Natasha, Li, Timao, Kumar, Dinender·1997·The FASEB Journal

Abstract

Current knowledge about adriamycin cardiomyopathy indicates that the major cause of this condition is increased oxidative stress although the drug's antitumor action in patients may involve other mechanisms. Controversies about the different antioxidants in preventing cardiomyopathy likely stem from the fact that antioxidants must be effective in both the lipid and water phases, and the dose must be optimal, in order to be protective. Probucol, an antioxidant and promoter of endogenous antioxidants, is one such agent. Conducting clinical trials with an optimal dose of probucol is the next step and should make this great anticancer drug safer and more efficient in the fight against the cancer.—Singal, P. K., Iliskovic, N., Li, T., Kumar, D. Adriamycin cardiomyopathy: pathophysiology and prevention. FASEB J. 11, 931–936 (1997)

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1096/fasebj.11.12.9337145

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 310

Metadata

Authors
Singal, P. K., Iliskovic, N., Li, T., & Kumar, D.
Venue
The FASEB Journal
Publisher
Wiley
Published
1997-10
Volume
11
Issue
12
Pages
931-936
ISSN
  • 0892-6638 (ISSN-L)
  • 1530-6860
OpenAlex
W1515699320
Cited by
310
References
1
FWCI
7.21
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Adriamycin cardiomyopathy: pathophysiology and prevention. https://app.cochat.ai/papers/10.1096/fasebj.11.12.9337145
The paper
Singal, P. K., Iliskovic, N., Li, T., & Kumar, D. (1997). Adriamycin cardiomyopathy: pathophysiology and prevention. The FASEB Journal. https://doi.org/10.1096/fasebj.11.12.9337145

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.